MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202411030670 A) filed by Shoolini University Of Biotechnology And Management Sciences, Solan, Himachal Pradesh, on April 17, 2024, for 'an iot-based hematofluorometry cancer detecting device.'
Inventor(s) include Dr. Pradeep Bhardwaj; Dr. Gaurav Gupta; Mr. Anitya Gupta; Aditi Kulshreshta; and Sataditya Jana.
The application for the patent was published on Oct. 31, under issue no. 44/2025.
According to the abstract released by the Intellectual Property India: "The present invention introduces an innovative AI-driven cancer detection device that utilizes IoT technology to enable early and post-cancer detection through the analysis of multiple blood factors. Furthermore, incorporating a mathematical 10 algorithm and advanced techniques like the coulter counter, blood chemical analyzer, and lipid analyzer, the device offers a comprehensive assessment of cancer tendencies from a single blood sample. This holistic approach enhances screening accuracy and efficiency, providing valuable insights into individual cancer risk profiles. In overall, this invention represents a significant advancement 15 in personalized cancer screening, offering accurate insights into cancer risk profiles and contributing to improved patient outcomes."
Disclaimer: Curated by HT Syndication.
